Literature DB >> 26361536

Valproic Acid-Induced Hyperammonemic Encephalopathy as a Cause of Neurologic Deterioration after Unruptured Aneurysm Surgery.

Sangkook Lee1, Jinhwan Cheong1, Choonghyun Kim1, Jae Min Kim1.   

Abstract

Neurological deficits after brain surgery are not uncommon, and correct and prompt differential diagnosis is essential to initiate appropriate treatment. We describe a patient suffering from loss of consciousness due to hyperammonemia, following valproic acid treatment after surgery for an unruptured cerebral aneurysm. A 57-year-old female patient underwent successful aneurysmal neck clipping to correct an unruptured aneurysm. Her postoperative course was good, and she received anti-epileptic therapy (valproic acid) and a soft diet. Within a few days the patient experienced mental deterioration. Her serum valproic acid reached toxic levels (149.40 mg/L), and serum ammonia was fifteen times the upper normal limit (553 mmol/L; normal range, 9-33 mmol/L). After discontinuation of valproic acid and with conservative treatment, the patient recovered without any complications. Valproate-induced hyperammonemic encephalopathy is an unusual but serious neurosurgical complication, and should not be disregarded as a possible cause of neurological deficits after neurovascular surgery. Early diagnosis is crucial, as discontinuation of valproic acid therapy can prevent serious complications, including death.

Entities:  

Keywords:  Encephalopathy; Hyperammonemia; Valproic acid

Year:  2015        PMID: 26361536      PMCID: PMC4564752          DOI: 10.3340/jkns.2015.58.2.159

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  9 in total

1.  Valproate-induced hyperammonemia and seizures: perioperative concerns.

Authors:  Rakesh Garg; Rani A Sunder
Journal:  Paediatr Anaesth       Date:  2011-10       Impact factor: 2.556

2.  Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.

Authors:  H M Hamer; S Knake; U Schomburg; F Rosenow
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

3.  Severe acute hyperammonemia after brief exposure to valproate.

Authors:  Aubrey L Eubanks; Betzabel Aguirre; James A Bourgeois
Journal:  Psychosomatics       Date:  2008 Jan-Feb       Impact factor: 2.386

Review 4.  Valproate-induced hyperammonemic encephalopathy.

Authors:  N Segura-Bruna; A Rodriguez-Campello; V Puente; J Roquer
Journal:  Acta Neurol Scand       Date:  2006-07       Impact factor: 3.209

Review 5.  Valproate-induced hyperammonemic encephalopathy.

Authors:  Alberto Verrotti; Daniela Trotta; Guido Morgese; Francesco Chiarelli
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

6.  Hyperammonemia following intravenous valproate loading.

Authors:  Jennifer L DeWolfe; Robert C Knowlton; Mark T Beasley; Stacey Cofield; Edward Faught; Nita A Limdi
Journal:  Epilepsy Res       Date:  2009-03-18       Impact factor: 3.045

Review 7.  Neurobiology of ammonia.

Authors:  Vicente Felipo; Roger F Butterworth
Journal:  Prog Neurobiol       Date:  2002-07       Impact factor: 11.685

8.  Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.

Authors:  Ming-Feng Tsai; Chen-Yin Chen
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

9.  Valproate-induced hyperammonemic encephalopathy.

Authors:  Hsiao-Feng Chou; Rei-Cheng Yang; Cheng Ying Chen; Yuh-Jyh Jong
Journal:  Pediatr Neonatol       Date:  2008-10       Impact factor: 2.083

  9 in total
  4 in total

Review 1.  Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.

Authors:  Xiaopeng Guo; Junji Wei; Lu Gao; Bing Xing; Zhiqin Xu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

2.  Valproate-associated hyperammonemic encephalopathy in subarachnoid hemorrhage: a diagnosis to consider.

Authors:  Vivian Fuellis; Pedro Grille; Federico Verga; Luis Urbán Alfaro; Lucciano Grasiuso; Marcelo Barbato
Journal:  Rev Bras Ter Intensiva       Date:  2022 Jan-Mar

3.  The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis.

Authors:  Long He; Shuting Wen; Zhuotai Zhong; Senhui Weng; Qilong Jiang; Hong Mi; Fengbin Liu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

4.  Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review.

Authors:  Tressa McMorris; Angela Chu; Lynn Vu; Amanda Bernardini
Journal:  Ment Health Clin       Date:  2021-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.